Study on Clinical Effectiveness of L-Oxiracetam Injection

NCT04205565 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

591

Enrollment

INDUSTRY

Sponsor class

Conditions

Craniocerebral Injury

Interventions

DRUG: Test group: L-oxiracetam Injection
DRUG: Control group: Oxiracetam Injection
DRUG: Placebo group: Placebo Injection

Sponsor

Nanjing Yoko Biomedical Co., Ltd.